IRIX vs LIVN

IRIDEX Corporation vs LivaNova PLC — Valuation Comparison 2026

IRIX

Electromedical & Electrotherapeutic Apparatus
IRIDEX Corporation
Quality
6.1
out of 10
Value Trap
24
SAFE
Price
$1.05
Last close
Models
12/13
Active
VS

LIVN

Electromedical & Electrotherapeutic Apparatus
LivaNova PLC
Quality
8.7
out of 10
Value Trap
17
SAFE
Price
$73.80
Last close
Models
13/13
Active

Model-by-Model Comparison

ModelType IRIX Fair ValueIRIX Upside LIVN Fair ValueLIVN Upside
Bayesian DCF Intrinsic $0.22 -79.4% $27.36 -62.9%
Earnings Power Value Intrinsic $2.12 +105.7% $26.31 -64.4%
EROIC Spread Intrinsic $•••.•• ••.•% $•••.•• ••.•%
First Chicago Scenario $•••.•• ••.•% $•••.•• ••.•%
Markov DDM Intrinsic $•••.•• ••.•% $•••.•• ••.•%
ML-RIV Intrinsic $•••.•• ••.•% $•••.•• ••.•%
Dynamic NAV Asset-Based $•••.•• ••.•% $•••.•• ••.•%
PWERM Option-Based $•••.•• ••.•% $•••.•• ••.•%
Regime Cross-Sectional Relative $•••.•• ••.•% $•••.•• ••.•%
Sentiment SOTP Hybrid $•••.•• ••.•% $•••.•• ••.•%
CUCE Ensemble Ensemble $•••.•• ••.•% $•••.•• ••.•%
FTNN Topology Relative $•••.•• ••.•% $•••.•• ••.•%
RCMH-DCF Intrinsic $•••.•• ••.•% $•••.•• ••.•%
🔒

Unlock Full 13-Model Comparison

Access all valuation models for IRIX vs LIVN — including EROIC Spread, First Chicago, Markov DDM, PWERM, and 7 more.

Access Full Analysis — From $27/mo →

IRIX vs LIVN — Which Stock Is More Undervalued?

LIVN scores higher with a 8.7/10 quality rating vs IRIX's 6.1/10. Both stocks are analyzed daily using SEC EDGAR filings across 13 independent models.

Comparing IRIDEX Corporation (IRIX) and LivaNova PLC (LIVN) across 13 institutional-grade valuation models reveals how each company's intrinsic value stacks up against its market price. CirclFi's engine processes SEC EDGAR 10-K and 10-Q filings, FRED macroeconomic data, and GDELT news sentiment to generate independent fair value estimates daily.

IRIX currently trades at $1.05 with a QOC of 6.1/10, while LIVN trades at $73.80 with a QOC of 8.7/10.

Both companies are analyzed with models spanning intrinsic (Bayesian DCF, EPV), scenario-based (First Chicago), regime-switching (Markov DDM, RCMH-DCF), machine learning (ML-RIV, FTNN Topology), and ensemble methods (CUCE).